Status:
COMPLETED
Minimum Effective Volume of Ropivacaine 7.5 mg/ml for the Lateral and Sagittal Infraclavicular Brachial Plexus Block
Lead Sponsor:
University Hospital of North Norway
Conditions:
Pain
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Systemic LA toxicity is an important complication of regional anesthesia. Lowering the LA dose is one of the strategies to reduce this risk. For upper limb blocks it is well documented that ultrasound...
Detailed Description
The blocks will be performed as previously described, by an anesthesiologist with LSIB expertise. The lateral, medial and posterior cords are the target of infra-clavicular brachial plexus blocks. Dur...
Eligibility Criteria
Inclusion
- Patients of American Society of Anesthesiologists physical status (ASA) I-II
- Scheduled for surgery distal to the elbow.
- Duration of surgery \>1 hour.
- Age 18-65 years,
- Body mass index 20-35 kg/m2
Exclusion
- Pregnancy
- Any contraindication to regional anesthesia
- Patients on major opioids because of chronic pain
- Atrioventricular block
- Pacemaker
- Diabetes
- Peripheral neuropathy
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01493986
Start Date
February 1 2012
End Date
July 1 2012
Last Update
September 11 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of North Norway
Tromsø, Troms, Norway, 9038